Healthcare and life sciences companies and their counsel turn to CRA for investigations and disputes relating to fraud, qui tam and false claims matters, Stark/anti-kickback, and voluntary self-disclosures. We can also serve as an Independent Review Organization or an Independent Monitor. Our industry knowledge and expertise in economics, finance, accounting, and business strategy make us uniquely qualified to assist in all phases of these matters.
We provide consultation and expert testimony in fraud and False Claims Act matters involving promotion, marketing, pricing, reimbursement, and distribution policies. Leveraging our expertise we also evaluate allegations including kickbacks leading to medically inappropriate provision of goods and services, inappropriate referrals, up-coding, unbundling, deceptive marketing, promotion of drugs for off-label uses not approved by the FDA, fraudulent billing practices, or retention of overpayments.
- 01FCPA investigation at a medical device companyCRA was engaged by a medical device company that needed to investigate allegations of bribery in India. The company was in the process of selling its Indian...View engagement
- 02Investigation of Medicare claims payment processorMembers of CRA’s team were hired to investigate a payment processor of Medicare claims related to home health aides in approximately 27 states. The team was...View engagement
- 03Hired to analyze the fair market value of servicesRetained to analyze the fair market value of services provided by an affiliate-owned provider of oncology-related services in order to effectively address and...View engagement